Hyundai Bioscience Co. Ltd (048410) — Capital Reinvestment Ratio
Hyundai Bioscience Co. Ltd (048410) has a Capital Reinvestment Ratio of 0.96x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩2.26 Billion) in capital expenditures (₩2.17 Billion). Check tangible net worth ratio of Hyundai Bioscience Co. Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hyundai Bioscience Co. Ltd Capital Reinvestment Ratio (2008–2024)
This chart tracks Hyundai Bioscience Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Hyundai Bioscience Co. Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year Capital Reinvestment Ratio for Hyundai Bioscience Co. Ltd from 2008 to 2024. See Hyundai Bioscience Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | ₩2.26 Billion | ₩2.17 Billion | ▼ -71.4% |
| 2020 | 3.36x | ₩7.50 Billion | ₩25.20 Billion | ▲ +906.0% |
| 2019 | 0.33x | ₩9.18 Billion | ₩3.07 Billion | ▼ -76.3% |
| 2018 | 1.41x | ₩5.01 Billion | ₩7.07 Billion | ▼ -81.0% |
| 2015 | 7.41x | ₩87.36 Million | ₩647.57 Million | ▲ +980.0% |
| 2014 | 0.69x | ₩1.22 Billion | ₩840.18 Million | ▲ +917.4% |
| 2011 | 0.07x | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩10.37 Billion | ₩3.92 Billion | — |